Objective: To investigate the use of a biologic TNF-alpha inhibitor, etanercept was given by perispinal extrathecal administration for the treatment of AD. Methods: This was a prospective ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th International ...

announced that data from the Phase 2a clinical trial of its oral TNF-alpha (TNF-α) inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th ...

Etanercept is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human p75 TNF-alpha cellular receptor linked to the Fc portion of human immunoglobulin (Ig ...

The incidence rate of herpes zoster in patients treated with conventional DMARDs was 5.6 per 1,000 patient-years, and increased to 11.1 per 1,000 patient-years in those treated with anti-TNF antibody ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

TNF inhibitors, the original biologic agents ... then stain the tissue for immunohistochemistry markers, such as TNF-alpha, IL-17, -23, -36, and see which one was expressed, then decide on ...

As with other drugs, Remicade (infliximab) can cause side effects, such as infusion reactions. If you are not able to tolerate side effects of Remicade, talk with your doctor or pharmacist.